Purchase Order 75N94022P00439
Award Date 6/13/22
Potential Completion Date 10/28/22
Potential Value $9.7K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53719, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Wicell Research Institute, Inc., a non-profit organization, by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services. The contract, valued at $16,137,048.00, is for the provision of human pluripotent stem cell lines, testing, and related services to support biomedical research. Wicell is a global leader in stem cell banking and distribution, and has provided specific cell lines to the National Institutes...
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Wicell Research Institute, Inc., a non-profit organization. The contract, valued at $187,372.95, is for the provision of human pluripotent stem cell lines, testing, and related services to support the NHLBI's biomedical research initiatives. Wicell Research Institute, a subsidiary of the Wisconsin Alumni Research Foundation, is a global...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Human Genome Research Institute to the non-profit Wicell Research Institute, Inc. for services related to the karyotype analysis and fluorescence in situ hybridization (FISH) testing of human cell lines. The $17,178.50 contract is for the delivery of these specific testing and analysis services on human pluripotent stem cell lines to support biomedical research...
- The National Institutes of Health awarded a $249,942 firm fixed price purchase order to Wicell Research Institute, Inc. to obtain 128 specific human pluripotent stem cell lines in support of the Helping to End Addiction Long-term Initiative. The award was made non-competitively based on Wicell being the only source capable of providing the cell lines due to scientific continuity needs. Prior to shipment, each cell line must undergo testing to verify identity, sterility, and normal karyotype....
- This $238,000.00 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the New York Stem Cell Foundation, Inc., a non-profit organization that conducts stem cell research. The contract is for the derivation of induced pluripotent stem cells, which aligns with the foundation's work in generating stem cell lines, differentiating them into various cell types, and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development, a civilian agency of the U.S. government, to Affymetrix, Inc. for the delivery of arrays of human pluripotent stem cell lines. The contract has a ceiling value of $12,000.00 and a completion date of September 12, 2011. The contract does not have a set-aside designation. As this is a purchase order, the prime contractor Affymetrix, Inc. is the only party involved in the...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Applied Stemcell, Inc. for $9,027.20. The contract, which has no set-aside designation, was awarded on April 27, 2011 for gene editing services to generate customized cell and animal models, including knockout mouse models, reporter cell lines, and stem cell models with disease-associated...
- This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells,...
- This is a $1,405,000.00 firm fixed price purchase order contract awarded by the National Human Genome Research Institute, a component of the Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for services related to beta cell differentiation and cell assays, which aligns with the original solicitation that sought the development of assays to evaluate the differentiation of stem cells into insulin-producing beta cells. No...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $150,000.00 firm fixed-price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines, differentiating stem cells into insulin-producing beta cells, and expanding and validating neural...